About Plenteous Pharmaceuticals Limited
Data last updated:
Plenteous Pharmaceuticals Limited is a public limited company based in Delhi, India, a subsidiary of Akums Drugs And Pharmaceuticals Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 11 December 2008 and has been in existence for over 18 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24232DL2008PLC185686. Its GSTIN is 07AAECP9062A1ZL (Delhi). The company holds 7 GST registrations, of which 6 are active.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors including Pooja Sharma (Whole-Time Director) and Neetika Goel.
Its last annual general meeting (AGM) was held on 14 June 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at 210 2nd Floor Mohan Place Lsc Block – C Saraswati Vihar, Delhi, India – 110034.
As per the financials filed for FY 2026, the company reported a revenue of ₹37.09 Cr, a decline of 27% compared to the previous year. For the same year it recorded a net loss of ₹10.7 Cr (net margin -28.8%) and EBITDA of -₹6.68 Cr (EBITDA margin -18%). Revenue has declined at a compounded annual rate (CAGR) of 30% over three years and 20% over five years.
The company has about 3 employees on its provident fund (EPFO) records.
As per MCA filings, the company has satisfied charges of ₹47 Cr on record. Court records list 43 cases involving the company, including 39 filed by the company and 4 filed against it; 14 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website plenteous.net.
Company details
Contact details
Plenteous Pharmaceuticals Limited's registered office is in Delhi, Delhi. Its website is plenteous.net. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address210 2nd Floor Mohan Place Lsc Block – C Saraswati Vihar, Delhi, India – 110034
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Plenteous Pharmaceuticals Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Plenteous Pharmaceuticals is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Plenteous Pharmaceuticals Limited, buy the company report.
Financials of Plenteous Pharmaceuticals Limited
FY 2026 filings availablePlenteous Pharmaceuticals Limited reported revenue of ₹37.09 Cr (down 27% YoY) for FY 2026.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 20% over five years, including a 27% fall in the latest year. EBITDA fell 16% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | ₹37.09 Cr | ||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹6.68 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹10.7 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -18% | ||||
| Net Profit Margin | -28.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Plenteous Pharmaceuticals Limited, buy the company report.
Board of directors of Plenteous Pharmaceuticals Limited
Plenteous Pharmaceuticals has 3 current directors and 10 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pooja Sharma Also directs: May and Baker Pharmaceuticals Limited | Whole-Time Director | 24 Nov 2017 | 8 Years 11 Months | Current |
| Neetika Goel Also directs: Parke Davis Healthcare Limited, Abbott Pharma Limited, Nicholas Healthcare Limited and 1 more | Director | 06 Nov 2024 | 2 Years 0 Months | Current |
| Gopi Nath Sahu | Additional Director | 05 Aug 2026 | 0 Years 3 Months | Current |
Auditor
Plenteous Pharmaceuticals Limited is audited by T A M S & Co. LLP for the financial year 2026.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| T A M S & Co. LLP | FY 2026 | 038010N/N500416 |
Shareholding
The shareholding of Plenteous Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2025, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Plenteous Pharmaceuticals Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Mar 2023 | 100687919 | Jp Morgan Chase Bank, N.A. | ₹40 Cr | Satisfied | |
| 29 Jun 2019 | 100273798 | Hdfc Bank Limited | ₹5 Cr | Satisfied | |
| 12 Dec 2011 | 10324921 | Icici Bank Limited | ₹2 Cr | Satisfied |
To see the full charge records of Plenteous Pharmaceuticals Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Plenteous Pharmaceuticals Limited has 43 court cases on record: 39 filed by Plenteous Pharmaceuticals, 4 filed against it. 14 cases are pending and 29 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 37 | 4 | 14 |
| High courts | 6 | 0 | 0 |
Cases on record (5 of 43)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, North West, Delhi | Court case (CS (COMM.)) | Filed by the company against Ado Remedies Private Limited | Pending |
| District court, North West, Delhi | Court case (CS (COMM.)) | Filed by the company against an individual | Pending |
| District court, North West, Delhi | Court case (CS (COMM.)) | Filed by the company against an individual | Pending |
| District court, North West, Delhi | Court case (CS (COMM.)) | Filed by the company against an individual | Pending |
| District court, North West, Delhi | Court case (CS (COMM.)) | Filed by the company against Babu Lal Saini Proprietor of Ms Montex Pharmaceuticals | Pending |
To see the full case history of Plenteous Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Plenteous Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Plenteous Pharmaceuticals Limited has a workforce of 3 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.
Headcount by financial year
| Financial year | Employees (EPFO) |
|---|---|
| FY 2026-27 | 3 |
| FY 2025-26 | |
| FY 2024-25 | |
| FY 2023-24 | |
| FY 2022-23 | |
| FY 2021-22 | |
| FY 2020-21 | |
| FY 2019-20 | |
| FY 2018-19 | |
| FY 2017-18 | |
| FY 2016-17 |
To see the full employee and EPFO history of Plenteous Pharmaceuticals Limited, buy the company report.
GST
Plenteous Pharmaceuticals has 7 GST registrations: 6 active and 1 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AAECP9062A1ZL | Delhi | Active | 01 Jul 2017 |
| 07AAECP9062A2ZK | Delhi | Active | 19 Mar 2025 |
| 06AAECP9062A1ZN | Haryana | Active | 01 Jun 2018 |
| 05AAECP9062A2ZO | Uttarakhand | Active | 19 Aug 2020 |
To see the full GST registrations and return filing status of Plenteous Pharmaceuticals Limited, buy the company report.
Recent activity
Plenteous Pharmaceuticals Limited has 23 board changes on record since 2008: 13 appointments and 10 cessations. The latest: Gopi Nath Sahu was appointed as Additional Director on 05 Aug 2026.
20 earlier events are in the company report.
Frequently asked questions
Plenteous Pharmaceuticals is an active public limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 11 December 2008 (18+ years old) and is registered under CIN U24232DL2008PLC185686.
Plenteous Pharmaceuticals has 3 current directors:
- Pooja Sharma - Whole-Time Director
- Neetika Goel - Director
- Gopi Nath Sahu - Additional Director
The latest financial statements of Plenteous Pharmaceuticals on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 14 June 2026. Year-wise statements from 2015 are in the company report.
The GSTIN of Plenteous Pharmaceuticals is 07AAECP9062A1ZL, registered in Delhi. The company has 7 GST registrations in all, of which 6 are active and 1 is cancelled or inactive. Other active GSTINs include 07AAECP9062A2ZK (Delhi), 06AAECP9062A1ZN (Haryana), 05AAECP9062A2ZO (Uttarakhand).
The CIN (Corporate Identification Number) of Plenteous Pharmaceuticals is U24232DL2008PLC185686. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Plenteous Pharmaceuticals has 43 court cases on record: 39 filed by the company and 4 filed against it. 14 are pending. Most are in the district courts.
Plenteous Pharmaceuticals was incorporated on 11 December 2008, making it 18+ years old. It is registered with the Registrar of Companies, Delhi.
Gopi Nath Sahu was appointed as Additional Director on 05 Aug 2026. Kusum Sharma ceased to be Director on 07 Nov 2024. Neetika Goel was appointed as Director on 06 Nov 2024. Plenteous Pharmaceuticals has 23 board changes on record in total.
Plenteous Pharmaceuticals can be reached through the website plenteous.net. Its registered office is in Delhi, India.
The registered office of Plenteous Pharmaceuticals is at 210 2nd Floor Mohan Place Lsc Block – C Saraswati Vihar, Delhi, India – 110034.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
